After struggling to maintain breastfeeding for 2 babies during medical training, I hope this may help some lactating women trainees in the future. A true team effort with Elizabeth Prsic MD, advice from Gretchen Colbenson, MD and with amazing support from the Yale School of Medicine GME Office.

Really looking forward to this⬇️!!! UPMC Hillman Cancer Center Magee-Womens Research Institute & Foundation Dr. Steffi Oesterreich Rachel Gottschalk Rachael Gordon MD, PhD

#SABCS22 Don’t forget to register for the in-person GRASP reception at SABCS ! Let’s connect !

Could not be more excited that this program is helping lactating trainees! Elizabeth Prsic MD

Anyone who has ever been to an E.R. knows that wait times can stretch for hours. But at NYU the wealthy often don't wait. They get swift access to tests & private rooms. nytimes.com/2022/12/22/hea… Here's our story, w/ the indefatigable Sarah Kliff, Virginia Hughes & David Enrich

Proud of my residency Yale Internal Medicine and PD Mark D. Siegel for advocating for IMGs, immigrants and others marginalized particularly in academic medicine!

Congrats, Fred Howard, such an important and huge analysis!

Dealing with private for-profit insurance companies, which often try to impede treatment for patients who desperately need it, has been by far the worst part of being a practicing oncologist. It's time we all have a say in this matter!

Are you living with oligometastatic #breastcancer? You may be eligible to participate in the Susan G. Komen supported CHLOE study which asks the question "can we cure oligometastatic HER2+ breast cancer?" Check out chloe.yalepathaws.org or contact Mariya Rozenblit #BCSM

🎙️ New CANCER BUZZ out now! Listen: bit.ly/3NuN1Ev. In this episode #CANCER BUZZ speaks with Dr. Mariya Rozenblit about a new registry study for a rare form of #breastcancer. #podcast

Thank you, UPMC Hillman Cancer Center for the support, and to NRG Oncology for giving me this opportunity! Looking forward to meeting the other fellowship recipients this summer!

A little late in sharing the good news that on my second try, I got the NIH Loan Repayment funded by the National Cancer Institute this year! Only possible because of my amazing mentors from fellowship Yale Hematology Oncology Fellows and those UPMC Hillman Cancer Center Magee-Womens Research Institute & Foundation and their true collaborative nature! #NIHLRP

The upcoming #ILCSymposium is deadline for us to get papers on #lobular #breastcancer on #bioRxiv (and hopefully soon published) Adrian Lee #1: Osama Shiraz Shah, PhD used spatially-resolved transcriptomic, genomic, and single-cell approaches to study mixed ductal lobular brca 1/4🧵

Great to see SABCS catching up to other major conferences on this👏! They also added specifics on dedicated nursing spaces to their website - sabcs.org/OnsiteServices…. Sad to see the 6 months age requirement... still don't know how I will attend with a 3-months old.

Grateful and proud to speak about a topic near and dear to my heart alongside Ayaka Sugiura (Vanderbilt MSTP), Talia H. Swartz, and other inspiring women a in Nature Medicine Comment piece today! APSA #physicianscientists #doubledocs nature.com/articles/s4159…

1/ Breast cancer with chest wall metastases is a devastating disease with high unmet need. Translational Breast Cancer Research Consortium #TBCRC044 clinical trial led by Dr. Neelima Vidula MGH Breast Oncology and Hope Rugo is currently enrolling patients.

Registration for the Pittsburgh Annual Oncology Symposium: Experts and Evidence 2024 is open! Join us on August 23rd at the Sheraton Pittsburgh Hotel at Station Square by clicking this link: tinyurl.com/ExpertsAndEvid… or scanning the QR code. Early-bird pricing valid until July 1st

This year, I joined the Steel City Research Warriors team for the Komen Pittsburgh MORE THAN PINK Walk. Please support Komen's mission of ending breast cancer as we know it. Join us in Schenley Park for the walk on May 19th! secure.info-komen.org/site/TR?pg=per…

Top 20 Breast Cancer Abstracts – #ASCO 2024 #bcsm #asco24

CDK4/6 inhibitors are transforming HR+/HER2- #BreastCancerTreatment. This review by Tara Magge, Sneha Rajendran, Adam Brufsky, & Julia Foldi, MD PhD highlights the benefits & limitations of these therapies & the emerging role of ribociclib & abemaciclib. 🗞️ link.springer.com/article/10.100…